Product Name
Glucosidase 2 subunit beta Recombinant Mouse Monoclonal Antibody [A6H9-R] - BSA and Azide free
Antibody Type
Recombinant Mouse Monoclonal Antibody
Immunogen
Recombinant protein within human Glucosidase 2 subunit beta aa 51-250.
Target Molecular Weight
Predicted band size: 59 kDa
Positive Control
HeLa cell lysate, 293T cell lysate, Daudi cell lysate, Jurkat cell lysate, A431 cell lysate.
Storage Instructions
Store at 2-8℃. Avoid freeze.
Purification Method
Protein A affinity purified.
Function
Regulatory subunit of glucosidase II that cleaves sequentially the 2 innermost alpha-1,3-linked glucose residues from the Glc(2)Man(9)GlcNAc(2) oligosaccharide precursor of immature glycoproteins. Required for efficient PKD1/Polycystin-1 biogenesis and trafficking to the plasma membrane of the primary cilia (By similarity). This gene encodes the beta-subunit of glucosidase II, an N-linked glycan-processing enzyme in the endoplasmic reticulum. The encoded protein is an acidic phosphoprotein known to be a substrate for protein kinase C. Mutations in this gene have been associated with the autosomal dominant polycystic liver disease. Alternative splicing results in multiple transcript variants.
Background References
1. Huang R. et. al. PRKCSH Alternative Splicing Involves in Silica-Induced Expression of Epithelial-Mesenchymal Transition Markers and Cell Proliferation. Dose Response. 2020 May
2. Shin GC. et. al. PRKCSH contributes to tumorigenesis by selective boosting of IRE1 signaling pathway. Nat Commun. 2019 Jul
Synonyms
80K-H protein antibody
AGE-binding receptor 2 antibody
AGE-R2 antibody
G19P1 antibody
GLU2B_HUMAN antibody
Glucosidase 2 subunit beta antibody
Glucosidase II beta subunit antibody
Glucosidase II subunit beta antibody
Hepatocystin antibody
PCLD antibody
Expand
80K-H protein antibody
AGE-binding receptor 2 antibody
AGE-R2 antibody
G19P1 antibody
GLU2B_HUMAN antibody
Glucosidase 2 subunit beta antibody
Glucosidase II beta subunit antibody
Glucosidase II subunit beta antibody
Hepatocystin antibody
PCLD antibody
PKCSH antibody
PLD1 antibody
PRKCSH antibody
Protein kinase C substrate 60.1 kDa protein heavy chain antibody
Protein kinase C substrate 80 Kda protein antibody
Protein kinase C substrate 80K-H antibody
Protein kinase C substrate, 80 Kda protein antibody
Collapse
-
This data was developed using HA601276, the same antibody clone in a different buffer formulation.
Western blot analysis of Glucosidase 2 subunit beta on different lysates with Mouse anti-Glucosidase 2 subunit beta antibody (HA601276) at 1/1,000 dilution.
Lane 1: HeLa cell lysate
Lane 2: 293T cell lysate
Lane 3: Daudi cell lysate
Lane 4: Jurkat cell lysate
Lane 5: A431 cell lysate
Lysates/proteins at 20 µg/Lane.
Predicted band size: 59 kDa
Observed band size: 80 kDa
Exposure time: 5 minutes;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (HA601276) at 1/1,000 dilution was used in 5% NFDM/TBST at 4℃ overnight. Goat Anti-Mouse IgG - HRP Secondary Antibody (HA1006) at 1/50,000 dilution was used for 1 hour at room temperature.
-
☑ Knockdown (KD)
This data was developed using HA601276, the same antibody clone in a different buffer formulation.
Western blot analysis of Glucosidase 2 subunit beta on different lysates with Mouse anti-Glucosidase 2 subunit beta antibody (HA601276) at 1/2,000 dilution.
Lane 1: HAP1-parental cell lysate
Lane 2: HAP1-Glucosidase 2 subunit beta KD cell lysate
Lysates/proteins at 10 µg/Lane.
Predicted band size: 59 kDa
Observed band size: 75 kDa
Exposure time: 15 seconds; ECL: K1801;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (HA601276) at 1/2,000 dilution was used in primary antibody dilution (K1803) at 4℃ overnight. Goat Anti-Mouse IgG - HRP Secondary Antibody (HA1006) at 1/50,000 dilution was used for 1 hour at room temperature.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"